Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Alzheimers Dis ; 29(4): 783-91, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22337827

RESUMO

Reduced glucose utilization is likely to precede the onset of cognitive deficits in Alzheimer's disease (AD). Similar aberrant glucose metabolism can also be detected in the brain of several AD mouse models. Although the cause of this metabolic defect is not well understood, it could be related to impaired insulin signaling that is increasingly being reported in AD brain. However, the temporal relationship between insulin impairment and amyloid-ß (Aß) biogenesis is unclear. In this study using female AßPPsw/PS1ΔE9 mice, we found that the level of Aß40 was fairly constant in 6- to 15-month-old brains, whereas Aß42 was only significantly increased in the 15-month-old brain. In contrast, increased levels of IRß, IGF-1R, IRS1, and IRS-2, along with reduced glucose and insulin content, were detected earlier in the 12-month-old brains of AßPPsw/PS1ΔE9 mice. The reduction in brain glucose content was accompanied by increased GLUT3 and GLUT4 levels. Importantly, these changes precede the significant upregulation of Aß42 level in the 15-month-old brain. Interestingly, reduction in the p85 subunit of PI3K was only apparent in the 15-month-old AßPPsw/PS1ΔE9 mouse brain. Furthermore, the expression profile of IRß, IRS-2, and p85/PI3K in AßPPsw/PS1ΔE9 was distinct in wild-type mice of a similar age. Although the exact mechanisms underlining this connection remain unclear, our results suggest a possible early role for insulin signaling impairment leading to amyloid accumulation in AßPPsw/PS1ΔE9 mice.


Assuntos
Doença de Alzheimer/genética , Doença de Alzheimer/metabolismo , Peptídeos beta-Amiloides/metabolismo , Insulina/metabolismo , Fragmentos de Peptídeos/metabolismo , Transdução de Sinais/fisiologia , Fatores Etários , Doença de Alzheimer/patologia , Peptídeos beta-Amiloides/sangue , Precursor de Proteína beta-Amiloide/genética , Animais , Encéfalo/metabolismo , Densitometria , Modelos Animais de Doenças , Ensaio de Imunoadsorção Enzimática , Feminino , Regulação da Expressão Gênica/genética , Glucose/metabolismo , Proteínas Facilitadoras de Transporte de Glucose/genética , Proteínas Facilitadoras de Transporte de Glucose/metabolismo , Humanos , Camundongos , Camundongos Transgênicos , Mutação/genética , Fragmentos de Peptídeos/sangue , Presenilina-1/genética , Receptor de Insulina/genética , Receptor de Insulina/metabolismo , Transdução de Sinais/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...